Clinical Trials Directory

Trials / Completed

CompletedNCT00795223

Comparative Pain Control Between 0.2 or 0.3 Spinal Morphine and 0.25 or 0.5 % Bupivacaine for FNB After TKA

Comparative Effect of 0.2 or 0.3 Spinal Morphine and 0.25 or 0.5 % Bupivacaine for Femoral Nerve Block After Total Knee Replacement

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
160 (actual)
Sponsor
Mahidol University · Academic / Other
Sex
All
Age
45 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Comparative efficacy of 24 and 48 hours post operative pain control in single total knee replacement between intrathecal bupivacaine with 0.2 or 0.3 mg morphine together with 0.25 or 0.5 % bupivacaine for single femoral nerve block

Conditions

Interventions

TypeNameDescription
DRUGmorphine and bupivacaine0.3 mg morphine for spinal together with 0.5% bupivacaine for femoral nerve block
DRUGspinal morphine and marcaine0.3 mg spinal morphine together with 0.25% bupivacaine for femoral nerve block
DRUGmorphine and bupivacaine0.2 mg morphine for spinal 0.5% bupivacaine for femoral nerve block
DRUGmorphine and bupivacaine0.2 mg morphine for spinal together with 0.25% bupivacaine for femoral nerve block

Timeline

Start date
2008-10-01
Primary completion
2009-05-01
Completion
2009-05-01
First posted
2008-11-21
Last updated
2009-09-29

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT00795223. Inclusion in this directory is not an endorsement.